Archive

The lead story in the American Institute of Ultrasound in Medicine’s November 2nd newsletter features the work of Kevin Parker, the William F May Professor of Engineering at the University of Rochester. Dr. Parker has applied 19th-Century mathematical functions to modern ultrasound to create color

By WILL ASTOR Rochester Business Journal August 8, 2016 The Food and Drug Administration has given Vaccinex Inc.’s VX15 Huntington’s disease drug fast track status. Huntington’s disease is a relatively rare affliction, affecting an estimated one in 10,000 individuals. Still, for sufferers and their families

Once again, the University of Rochester has been ranked in the top 100 universities worldwide for the number of issued patents. In 2015, Rochester placed 41st in the world, with 48 issued U.S. patents. Duke University also had 48 patents and shares the 41st position

16 May 2016 New York, NY & Rochester, NY Taithera, Inc., a New York City based biotech company, and UR Ventures, the technology commercialization office of the University of Rochester, today announced plans to commercialize a bone-targeted therapeutic agent. This precision medicine technology, invented at

Munich – Health Care Originals won the Health & Wellness category of the Wearables Technologies Innovation World Cup for their Automated Device for Asthma Monitoring and Management (ADAMM) technology. They then went on to beat five other category winners to be named Overall Innovator of

A compound developed to protect the nervous system from HIV surprised researchers by augmenting the effectiveness of an investigational antiretroviral drug beyond anything expected. The potency of the combination treatment, tested so far in mice, suggests that it would be possible to rid the body

Telephus Medical LLC (Telephus), a biotechnology company focused on development of antibody therapies for antibiotic-resistant staphylococcal infections, today announced that the Japan Patent Office has issued Japanese patent number 5,837,215 covering monoclonal antibody compositions that bind and neutralize the endo-β-Nacetylglucosaminidase (Gmd) subunit of staphylococcal bifunctional

Richard Phipps, Ph.D., Professor of Environmental Medicine, is collaborating with Aubrey Woodroof, Ph.D. (founder of PermeaDerm, Inc., and inventor of the first bilaminate, biosynthetic, temporary wound dressing, Biobrane®), and BioDot, Inc. (a leader in the field of dispensing low volumes of fluids and powders) to